6.45
Atai Life Sciences N V Borsa (ATAI) Ultime notizie
Combining machine learning predictions for Atai Life Sciences N.V.2025 AllTime Highs & Accurate Trade Setup Notifications - newser.com
Can swing trading help recover from Atai Life Sciences N.V. lossesIPO Watch & Target Return Focused Stock Picks - newser.com
Atai’s Rollercoaster: Potential Breakthrough or Risky Path? - StocksToTrade
Why Atai Life Sciences Stock Was So Lively This Week - The Motley Fool
How institutional ownership impacts Atai Life Sciences N.V. stock2025 Stock Rankings & Community Trade Idea Sharing Platform - newser.com
Germany: atai raises US$130m from share offering as US FDA grants BTD to BPL-003 - Investors in Healthcare
Atai Life Sciences Prices $130 Million Share Offering - MarketScreener
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression - Investing News Network
atai Life Sciences Announces Proposed Public Offering of Common Shares - Investing News Network
Atai Life Sciences N.V. stock chart pattern explained2025 Fundamental Recap & Daily Stock Momentum Reports - newser.com
Quantitative breakdown of Atai Life Sciences N.V. recent move2025 Winners & Losers & Growth Focused Stock Pick Reports - newser.com
$130M Raise: atai Life Sciences Prices 23.7M Shares at $5.48 to Fund Clinical Development - Stock Titan
Atai Life Sciences N.V. (ATAI) Stock Rebounds as Company Launches New Share Offering - parameter.io
Atai, Beckley Get FDA Breakthrough Label for BPL-003; Launches Public Offering - MarketScreener
ATAI Life Sciences and Beckley Psytech Announce FDA Breakthrough Therapy Designation for BPL-003 - TradingView
atai Life Sciences, Beckley Psytech get FDA breakthrough therapy status for BPL-003 - Seeking Alpha
Atai Life Sciences Gets FDA Breakthrough Designation for Depression Treatment - MarketScreener
Proposed common-share offering: atai Life Sciences to fund clinical programs; Jefferies lead bookrunner - Stock Titan
Atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression - MarketScreener
atai Life Sciences Receives FDA Breakthrough for BPL-003 in TRD | ATAI Stock News - Stock Titan
Ranking Atai Life Sciences N.V. among high performing stocks via toolsWeekly Risk Summary & Scalable Portfolio Growth Methods - newser.com
How high can Atai Life Sciences N.V. stock goPortfolio Return Report & Community Trade Idea Sharing - newser.com
Can technical indicators confirm Atai Life Sciences N.V.’s reversal2025 Earnings Surprises & Stepwise Trade Signal Guides - newser.com
Atai Life Sciences N.V. stock retracement – recovery analysisInsider Buying & Daily Entry Point Trade Alerts - newser.com
Psychedelic stocks gain after positive remarks from GOP Senator in North Carolina - Seeking Alpha
Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside - Sahm
Tick level data insight on Atai Life Sciences N.V. volatilityQuarterly Profit Report & Risk Managed Investment Strategies - newser.com
Can Atai Life Sciences N.V. stock resist sector downturnsJuly 2025 Pullbacks & Safe Capital Growth Plans - newser.com
How Atai Life Sciences N.V. (9VC) stock responds to job market shiftsGold Moves & Short-Term Trading Alerts - newser.com
Is now a turning point for Atai Life Sciences N.V.Profit Target & Verified Swing Trading Watchlists - newser.com
Needham Initiates ATAI Life Sciences N.V at Buy With $12 Price Target - MarketScreener
Needham Initiates Coverage of Atai Life Sciences N.V. (ATAI) with Buy Recommendation - Nasdaq
ATAI Life Sciences files update on Beckley Psytech acquisition plans By Investing.com - Investing.com Nigeria
ATAI Life Sciences files update on Beckley Psytech acquisition plans - Investing.com
ATAI Life Sciences to Acquire Beckley Psytech - TipRanks
ATAI Life Sciences N.V. Announces Acquisition of Beckley Psytech - TradingView
Published on: 2025-10-10 04:54:45 - newser.com
ATAI Life Sciences N.V. (ATAI) Stock Analysis: A Biotech Gem With 107% Potential Upside - DirectorsTalk Interviews
Can trapped investors hope for a rebound in Atai Life Sciences N.V.Portfolio Growth Summary & Low Risk Growth Stock Ideas - newser.com
What to expect from Atai Life Sciences N.V. in the next 30 daysJuly 2025 Selloffs & Technical Confirmation Trade Alerts - newser.com
Evaluating Atai Life Sciences N.V. with trendline analysis2025 Market Overview & Fast Moving Stock Trade Plans - newser.com
What sentiment indicators say about Atai Life Sciences N.V. stockJuly 2025 Volume & Expert Approved Momentum Ideas - newser.com
Will Atai Life Sciences N.V. stock outperform growth indexes2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):